192 related articles for article (PubMed ID: 10976786)
1. Endothelin and endothelin receptor antagonism in heart failure.
Sütsch G; Kiowski W
J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S69-73. PubMed ID: 10976786
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of bosentan in patients with chronic heart failure.
Kiowski W; Sütsch G; Oechslin E; Bertel O
Heart Fail Rev; 2001 Dec; 6(4):325-34. PubMed ID: 11447307
[TBL] [Abstract][Full Text] [Related]
3. Bosentan and the endothelin system in congestive heart failure.
Ellahham SH; Charlon V; Abassi Z; Calis KA; Choucair WK
Clin Cardiol; 2000 Nov; 23(11):803-7. PubMed ID: 11097125
[TBL] [Abstract][Full Text] [Related]
4. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
[TBL] [Abstract][Full Text] [Related]
5. Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans.
Sütsch G; Bertel O; Kiowski W
Cardiovasc Drugs Ther; 1997 Jan; 10(6):717-25. PubMed ID: 9110115
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
[TBL] [Abstract][Full Text] [Related]
7. Endothelin and heart failure.
Nambi P; Clozel M; Feuerstein G
Heart Fail Rev; 2001 Dec; 6(4):335-40. PubMed ID: 11447308
[TBL] [Abstract][Full Text] [Related]
8. Rationale and perspective of endothelin-1 antagonism in acute heart failure.
Kiowski W; Suetsch G; Oechslin E; Schalcher C; Brunner-Larocca HP; Bertel O
J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S53-7. PubMed ID: 11811379
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
[TBL] [Abstract][Full Text] [Related]
10. Endothelin antagonists and heart failure.
Hürlimann D; Enseleit F; Noll G; Lüscher TF; Ruschitzka F
Curr Hypertens Rep; 2002 Feb; 4(1):85-92. PubMed ID: 11790297
[TBL] [Abstract][Full Text] [Related]
11. Role of endothelin-1 in myocardial failure.
Sam F; Colucci WS
Proc Assoc Am Physicians; 1999; 111(5):417-22. PubMed ID: 10519162
[TBL] [Abstract][Full Text] [Related]
12. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
[TBL] [Abstract][Full Text] [Related]
13. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.
Sütsch G; Kiowski W; Yan XW; Hunziker P; Christen S; Strobel W; Kim JH; Rickenbacher P; Bertel O
Circulation; 1998 Nov; 98(21):2262-8. PubMed ID: 9826312
[TBL] [Abstract][Full Text] [Related]
14. Reversing congestive heart failure with endothelin receptor antagonists.
Yazaki Y; Yamazaki T
Circulation; 1997 Apr; 95(7):1752-4. PubMed ID: 9107157
[No Abstract] [Full Text] [Related]
15. New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.
Suresh DP; Lamba S; Abraham WT
J Card Fail; 2000 Dec; 6(4):359-68. PubMed ID: 11145761
[TBL] [Abstract][Full Text] [Related]
16. [New expansion of endothelin research: perspectives for clinical application of endothelin-receptor antagonists].
Goto K; Miyauchi T
Nihon Yakurigaku Zasshi; 2003 Feb; 121(2):91-101. PubMed ID: 12616854
[TBL] [Abstract][Full Text] [Related]
17. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.
Kiowski W; Sütsch G; Hunziker P; Müller P; Kim J; Oechslin E; Schmitt R; Jones R; Bertel O
Lancet; 1995 Sep; 346(8977):732-6. PubMed ID: 7658874
[TBL] [Abstract][Full Text] [Related]
18. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
Borgeson DD; Grantham JA; Williamson EE; Luchner A; Redfield MM; Opgenorth TJ; Burnett JC
Hypertension; 1998 Mar; 31(3):766-70. PubMed ID: 9495259
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats.
Sakai S; Miyauchi T; Sakurai T; Yamaguchi I; Kobayashi M; Goto K; Sugishita Y
J Am Coll Cardiol; 1996 Nov; 28(6):1580-8. PubMed ID: 8917275
[TBL] [Abstract][Full Text] [Related]
20. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
